- Home
- CNET vs BIAF Comparison
CNET vs BIAF Comparison
Compare CNET & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNET | BIAF |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | Hong Kong | United States |
| Employees | N/A | 57 |
| Industry | Advertising | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 4.6M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNET | BIAF |
|---|---|---|
| Price | $0.72 | $1.04 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 501.2K | 226.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $46,633,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $20.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 34.20 | N/A |
| 52 Week Low | $0.60 | $0.16 |
| 52 Week High | $2.78 | $13.50 |
Technical Indicators
Market Signals| Indicator | CNET | BIAF |
|---|---|---|
| Relative Strength Index (RSI) | 36.07 | 47.36 |
| Support Level | $0.60 | $0.90 |
| Resistance Level | $0.88 | $1.45 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 28.22 | 28.57 |
Price Performance
Historical ComparisonAbout CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.